A 2-day-old with abnormal hip movement

Last updated: November 27, 2025Bookmark

A 2-day-old female infant born at 39 weeks via breech vaginal delivery is undergoing her routine newborn exam on day 2 of life. The baby is feeding well, active and has no apparent distress.

On examination, she is a healthy term neonate. There is a positive Barlow test and a positive Ortolani test on the left. There is no leg length discrepancy. No other congenital anomalies are noted.

Q1. What is the diagnosis?

Reveal answer

Developmental dysplasia of the hip (DDH)

DDH is an abnormal development of the hip characterised by dysplasia, subluxation and possible dislocation of the hip. It is the most common orthopaedic disorder in newborns.

Q2. What are the risk factors for this condition?

Reveal answer

Firstborn child (due to tight spacing in the uterine cavity)

Female (due to ligamentous laxity caused by circulating estrogens)

Family history of DDH (parents or siblings)

Fluid lacking (oligohydramnios)

Feet first (breech presentation especially when feet lie near the shoulders e.g. Frank breech)

Tight swaddling (especially with the hips and knees straight)

5 F’s: firstborn, female, family history, fluid lacking, feet first

Q3. What associated conditions should be looked for?

Reveal answer

Congenital muscular torticollis

Metatarsus adductus

Congenital knee dislocation

These condition can also be caused by intrauterine malpositioning – packaging disorders

Q4. What is the pathophysiology of this condition and how does it relate to its risk factors?

Reveal answer

Maternal and fetal ligamentous laxity due to hormonal influence (estrogen and relaxing) leads to intrauterine malpositioning

Mechanical factors (breech presentation, oligohydramnios, primigravida with reduced intrauterine space) also leads to intra-uterine malpositioning

Post-natal positioning (sweight swaddling with hip extended and adducted) exacerbates this instability

Due to this malpositioning there is poor contact between the femoral head and acetabulum leading to deficiency of the anterior and anterolateral acetabulum (the socket is shallow and unstable)

Bony changes:

Shallow and dysplastic acetabulum

Anteverted and anterolaterally deficient acetabulum

Pseudoacetabulum formation: the femoral head may articulate with the ilium at a false socket

Delay in teardrop development

Delayed ossific nucleus of the femur, anteversion, deformed head and coxa valgus

Intra-articular soft tissue changes:

Elongated and redundant capsule.

Thickened ligamentum teres

Thickened transverse acetabular ligament

Limbus formation as the displaced femoral head causes hypertrophy and inversion of the acetabular cartilage rim (creates a physical barrier to reduction)

Pulvinar muscles

Extra-articular soft tissue changes:

Tight adductors

Tight psoas tendon

Short abductors

Soft Tissue Changes in Developmental Dysplasia of the Hip
Bony changes in DDH

Q5. What are the phases (classification) of this condition?

Reveal answer
PhasePhysical exam
SubluxableBarlow-suggestive
DislocatableBarlow-positive
DislocatedOrtolani-positive if reducible, Ortolani negative if irreducible

Q6. What signs can be elicited during physical examination in this condition?

Reveal answer

AgeSigns
< 3 monthsPositive barlow, positive ortolani, Galeazzi (allis test), telescoping, asymmetric skin folds
3 – 12 monthsDecreased hip abduction (due to contracture), leg length discrepancy, Klisic test (for bilatral dislocation)
> 12 months (walking child)Pelvic obliquity, lumbar lordosis (due to hip contractures), trendelenburg gait (due to abductor insufficiency), toe-walking (to compensate for shortening of the affected side)

Q7. Describe the following tests: Barlow, Ortolani, Galeazzi (Allis), Klisic

Reveal answer

TestPurposeManeuverPositive finding
BarlowDislocatable hipAdduction + posterior pressureHip dislocates (”clunk”)
OrtolaniReducible hipAbduct + anterior liftHip reduces (”clunk”)
Galeazzi (Allis)Leg length discrepancyInspect with knees flexed at 90 degreesOne knee is lower
KlisicChronic dislocationLine drawn from the ASIS to trochanter linePoints below the umbilicus

Q8. Which radiographic reference lines are used to assess normal hip alignment on a paediatric pelvic radiograph?

Reveal answer

LineDescriptionImportance / Use
Hilgenreiner’s lineHorizontal line through triradiate cartilages (Y-shaped growth plate)Baseline for measuring acetabular angle; used in developmental dysplasia of the hip (DDH)
Perkins’ lineVertical line at lateral edge of acetabulum, perpendicular to Hilgenreiner’sDefines quadrants; femoral head should lie in inferomedial quadrant (displacement = DDH)
Shenton’s lineSmooth arc along inferior border of superior pubic ramus → medial femoral neckInterruption suggests hip dislocation, subluxation, or fracture
Acetabular angleAngle between Hilgenreiner’s line & acetabular roof lineIncreased angle indicates acetabular dysplasia
Klein’s lineLine along superior border of femoral neck; should intersect femoral epiphysisFailure = slipped capital femoral epiphysis (SCFE)

Q9. What investigations are useful for this condition?

Reveal answer

Ultrasound of the hip: for patients less than 6 months old

Acetabular dysplasia

Hip dislocation

X-ray of the hip: AP view of pelvis for patients older than 6 months when the ossific nucleus of the proximal femur appears

Shenton’s line (should be continuous)

Hilgenreiner’s line (femoral head ossification should be inferior to this line)

Perkin’s line (femoral head ossification should be medial to this line

Delayed ossification of the femoral head

Absent acetabular teardrop

Arthrogram: to confirm reduction after closed reduction under anaesthesia

MRI: to evaluate reduction of hip after closed reduction and spica casting

Q10. How is this condition treated?

Reveal answer

TreatmentDescriptionNota bene
Pavlik harnessFor children less than 6 months oldAssess every 4 – 6 weeks with ultrasound. Assess after 2 weeks if reduced → If reduced wear for 6 weeks → confirm after 6 weeks if reduced → if reduced wean off over 6 – 8 weeks.
Closed manipulative reduction (CMR) and hip spicaFor children 6 – 18 months oldReduction is confirmed using an arthrogram. Spica is changed every 6 weeks and worn for a total of 3 months.
Operative treatmentFor children older than 18 monthsIncludes open reduction +/- femoral/pelvic osteotomy

Q11. What are the principles of using a Pavlik harness?

Reveal answer

Dynamic splint (requires normal muscle function – works as the child kicks)

Use before the child can sit

Anterior strap flexes the hip to 90 – 100 degrees while the posterior strap abducts the hip to 45 degrees

Worn for 24 hours a day for 6 weeks

Q12. What advice can be given to parents regarding the hip spica?

Reveal answer

Small and frequent meals: to prevent bloating and constipation which can make the child uncomfortable in the cast

Perineal care: clean and dry perineum to prevent rashes and infection

Cast care: the cast should be dry, clean and intact all times. Use sponge bath only.

Q13. What is the safe zone of Ramsey?

Reveal answer

The safe zone of ramsey is the zone between maximum abduction and minimum adduction where the hip remains reduced

It should be at least 25 degrees. The wider the zone of safety the more stable the reduction.

If the safe zone of ramsey in children being treated for DDH with a spica is not more than 25 degrees adductor tenotomy can be performed

Q14. What complications may occur if this condition is untreated or poorly treated?

Reveal answer

Pavlik harness disease: erosion of the posterior acetabulum due to prolonged use of the Pavlik harness with the hip dislocated

Femoral nerve palsy: due to overflexion when using a Pavlik harness

Avascular necrosis of the femoral head: due to over-abduction > 60 degrees when using a Pavlik harness. This causes impingement of the retinacular branch of the medial femoral circumflex artery.

Recurrence (10%)

Chronic limp

Limb length discrepancy which leads to back pain, functional scoliosis and knee pain

Pain or decreased range of motion

Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Leave a Reply

A moment of your time
Step 1 of 2

You are the reason this exists. Got 60 seconds? Help us improve Hyperexcision for every medical student who uses it.

The Hyperexcision Team